All subjects | Stable disease | Partial response | Progression of disease | P value | |
Number (%) | 41 (100) | 13 (31.7) | 10 (24.4) | 18 (43.9) | |
Age (y, Mean ± SD) | 51 ± 11 | 53 ± 12 | 53 ± 8 | 49 ± 11 | 0.4514 |
Gender (%) | 0.4504 | ||||
Male | 38 (92.7) | 11 (84.6) | 10 (100) | 17 (94.4) | |
Female | 3 (7.3) | 2 (15.4) | 0 (0) | 1 (5.6) | |
Child-Pugh Class (%) | |||||
A | 41 (100) | 13 (100) | 10 (100) | 18 (100) | |
Hepatitis (%) | 0.3873 | ||||
Hepatitis B | 37 (90.2) | 11 (84.6) | 9 (90) | 17 (94.4) | |
Hepatitis C | 1 (2.4) | 0 (0) | 1 (10) | 0 (0) | |
None | 3 (7.3) | 2 (15.4) | 0 (0) | 1 (5.6) | |
BCLC Stage (%) | 0.051 | ||||
B | 15 (36.6) | 6 (46.2) | 6 (60) | 3 (16.7) | |
C | 26 (63.4) | 7 (53.8) | 4 (40.0) | 15 (83.3) |